A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
Clinical trial NCT03025698 · COMPLETED
Trial details
- NCT number
- NCT03025698
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-30
- Primary completion
- 2022-04-22
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.